Cel Gro Medication

What its generic name, brand name, classification, indications, contraindications, dosage, adverse effects/side effects and nursing responsibilities ## Dr priscibed me to hav celgro daily 2 times, to increas motility of my sperms, is it usfull, is it work if I hv it dailly once

1 REPLY

Drug Category

Growth hormone treatment refers to the use of growth hormone (GH) as a prescription medication - it is one form of Hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. GH is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 50 years. This arti...

Drug Index

Hydroxypropyl cellulose (HPC) is a derivative of cellulose with both water solubility and organic solubility. It is used as an excipient, and topical ophthalmic protectant and lubricant. Contents 1 Chemistry 2 Uses 3 See also 4 Notes and references Chemistry HPC is an ether of cellulose in which some of the hydroxyl groups in the repeating glucose units have been hydroxypropylated forming -OCH2CH(OH)CH3 groups using propylene oxide. The average number of substituted hydroxyl groups p...

My daughter has stage 4 renal cell carcinoma, the cancer has metastasized to her lungs, lymph nodes and vena cava vein. She has tried both Votrient and Sutent but the cancer has continued to grow. She has seen 3 different surgeons who all agree that surgery is not a option as the risk would far outweigh any benefits. She just started the drug Afinitor and I was wondering if anyone has had positive results with this medication. Know it's not realistic to only look at good postings but she could really use a little positive reinforcement about now. So far she hasn't experienced any severe side effects but if or when they kick in I know she could handle them a lot better if she had a some hope. Any postings would be truly appreciated. ## Has she looked over the manufacturer's w...

1 REPLY

We are interested in finding out whether abatacept has been successful in treating Giant Cell Arteritis, before joining the study group. My mother has recently lost 95% of her vision to this disease and is afraid to risk the remainder, but is resistant to the common treatment methods. All input is appreciated.

My husband has CTCL and is being told to take Targretin. Can anyone tell me if they have taken it and what side effects they had? Thank you ## Lois, There is an online support group of CTCL patients, many of whom are on Taragretin. They will be happy to share their experiences. Go to Association of Cancer Online Resources and look for the CTCL-MF group. ## Thank you, Judy for that very helpful post. It seems we haven't had a lot of people posting on here that have been using it. We do, however, have more information on the medication here: Can anyone post about experience using this drug?

2 REPLIES

Erlotinib

Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer.[2] Specifically it is used for NSCLC with mutations in the epidermal growth factor receptor (EGFR) — either an exon 19 deletion (del19) or exon 21 (L858R) substitution mutation — which has spread to other parts of the body.[2] It is taken by mouth.[2] Common side effects include rash, diar...

Drug Index

Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer.[2] Specifically it is used for NSCLC with mutations in the epidermal growth factor receptor (EGFR) — either an exon 19 deletion (del19) or exon 21 (L858R) substitution mutation — which has spread to other parts of the body.[2] It is taken by mouth.[2] Common side effects include rash, diar...

Osimertinib

Osimertinib, sold under the brand name Tagrisso,[3] is a medication used to treat non-small-cell lung carcinomas with specific mutations.[4][5] It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor. The most common side effects include diarrhea, rash, musculoskeletal pain, dry skin, skin inflammation around nails, sore mouth, fatigue and cough.[6] Osimertinib was approved for medical use in the Unit...

Drug Index

Osimertinib, sold under the brand name Tagrisso,[3] is a medication used to treat non-small-cell lung carcinomas with specific mutations.[4][5] It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor. The most common side effects include diarrhea, rash, musculoskeletal pain, dry skin, skin inflammation around nails, sore mouth, fatigue and cough.[6] Osimertinib was approved for medical use in the Unit...

Tazemetostat Hydrobromide

Tazemetostat, sold under the brand name Tazverik, is a medication used for the treatment of adults and adolescents aged 16 years and older with metastatic (when cancer cells spread to other parts of the body) or locally advanced (when cancer has grown outside the organ it started in, but has not yet spread to distant parts of the body) epithelioid sarcoma not eligible for complete resection (surgically removing all of a tissue, structure, or organ).[1] The most common side eff...

Erdafitinib

Erdafitinib, sold under the brand name Balversa, is an anti-cancer medication. It is a small molecule inhibitor of fibroblast growth factor receptor (FGFR) used for the treatment of cancer. FGFRs are a subset of tyrosine kinases which are unregulated in some tumors and influence tumor cell differentiation, proliferation, angiogenesis, and cell survival.[1][2] Astex Pharmaceuticals discovered the drug and licensed it to Janssen Pharmaceuticals for further develo...

Drug Index

Tazemetostat, sold under the brand name Tazverik, is a medication used for the treatment of adults and adolescents aged 16 years and older with metastatic (when cancer cells spread to other parts of the body) or locally advanced (when cancer has grown outside the organ it started in, but has not yet spread to distant parts of the body) epithelioid sarcoma not eligible for complete resection (surgically removing all of a tissue, structure, or organ).[1] The most common side eff...

Drug Index

Erdafitinib, sold under the brand name Balversa, is an anti-cancer medication. It is a small molecule inhibitor of fibroblast growth factor receptor (FGFR) used for the treatment of cancer. FGFRs are a subset of tyrosine kinases which are unregulated in some tumors and influence tumor cell differentiation, proliferation, angiogenesis, and cell survival.[1][2] Astex Pharmaceuticals discovered the drug and licensed it to Janssen Pharmaceuticals for further develo...

Gefitinib

Gefitinib, sold under the brand name Iressa, is a medication used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR, but resistances to gefitinib can arise through other mutations. It is marketed by AstraZeneca and Teva. It is on the World Health Organization's List of Essential Med...

Drug Index

Gefitinib, sold under the brand name Iressa, is a medication used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR, but resistances to gefitinib can arise through other mutations. It is marketed by AstraZeneca and Teva. It is on the World Health Organization's List of Essential Med...

Pazopanib Hydrochloride

Pazopanib, sold under the brand name Votrient, is an anti-cancer medication marketed worldwide by Novartis. It is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis. It has been approved for renal cell carcinoma and soft tissue sarcoma by numerous regulatory administrations worldwide.[3][4][5][6] Contents 1 Medical uses 2 Contraindications 3 Adverse effec...

Drug Index

Afatinib, sold under the brand name Gilotrif among others, is a medication used to treat non-small cell lung carcinoma (NSCLC).[2][3][4] It belongs to the tyrosine kinase inhibitor family of medications.[5] It is taken by mouth.[5][1] It is mainly used to treat cases of NSCLC that harbour mutations in the epidermal growth factor receptor (EGFR) gene.[6] It is on the World Health Org...

Afatinib

Afatinib, sold under the brand name Gilotrif among others, is a medication used to treat non-small cell lung carcinoma (NSCLC).[2][3][4] It belongs to the tyrosine kinase inhibitor family of medications.[5] It is taken by mouth.[5][1] It is mainly used to treat cases of NSCLC that harbour mutations in the epidermal growth factor receptor (EGFR) gene.[6] It is on the World Health Org...

Drug Index

Pazopanib, sold under the brand name Votrient, is an anti-cancer medication marketed worldwide by Novartis. It is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis. It has been approved for renal cell carcinoma and soft tissue sarcoma by numerous regulatory administrations worldwide.[3][4][5][6] Contents 1 Medical uses 2 Contraindications 3 Adverse effec...